Should Systematic Lymphadenectomy Be Performed in Suboptimally Debulked Patients with Stage III Ovarian Carcinoma? A Degog Study


Saygili U., Guclu S., Erten O., POSACI C.

OVARIAN CANCER: NEW RESEARCH, cilt.19, ss.157-170, 2009 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 19
  • Basım Tarihi: 2009
  • Dergi Adı: OVARIAN CANCER: NEW RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED)
  • Sayfa Sayıları: ss.157-170
  • Anahtar Kelimeler: lymphadenectomy, ovarian carcinoma, cytoreduction, survival, LONG-TERM SURVIVAL, PARA-AORTIC LYMPHADENECTOMY, LYMPH-NODE INVOLVEMENT, CYTOREDUCTIVE SURGERY, PARAAORTIC LYMPHADENECTOMY, NEOADJUVANT CHEMOTHERAPY, COMBINATION CHEMOTHERAPY, GYNECOLOGIC MALIGNANCIES, PELVIC LYMPHADENECTOMY, INTERVAL DEBULKING
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

The therapeutic importance of lymphadenectomy in ovarian carcinoma is controversial. The aim of this study is to determine whether systematic lymphadenectomy is necessary in suboptimally debulked patients with stage Ill ovarian carcinoma.